July 21, 2017 Uncategorized

CHMP recommends EU approval of Roche’s Gazyvaro for people with previously untreated advanced follicular lymphoma

Basel, 21 July 2017 CHMP recommends EU approval of Roche’s Gazyvaro for people with previously untreated advanced follicular lymphoma Pivotal GALLIUM study demonstrated that Gazyvaro-based treatment helped people with previously untreated follicular lymphoma live significantly longer without disease progression compared to MabThera-based treatment Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the EU Committee... Read more

July 21, 2017 Uncategorized

CHMP recommends EU approval for Roche’s TECENTRIQ (atezolizumab) in a specific type of metastatic lung and two types of metastatic bladder cancer

Basel, 21 July 2017 CHMP recommends EU approval for Roche’s TECENTRIQ (atezolizumab) in a specific type of metastatic lung and two types of metastatic bladder cancer TECENTRIQ as a potential treatment option for people with previously treated locally advanced or metastatic non-small cell lung cancer (NSCLC) TECENTRIQ as a potential treatment option for people with... Read more

July 21, 2017 Bio/Pharma/CRO Uncategorized

CHMP recommends EU approval for Roche’s TECENTRIQ (atezolizumab) in a specific type of metastatic lung and two types of metastatic bladder cancer

Basel, 21 July 2017 CHMP recommends EU approval for Roche’s TECENTRIQ (atezolizumab) in a specific type of metastatic lung and two types of metastatic bladder cancer TECENTRIQ as a potential treatment option for people with previously treated locally advanced or metastatic non-small cell lung cancer (NSCLC) TECENTRIQ as a potential treatment option for people with... Read more

July 18, 2017 Uncategorized

Bendable biosensors from flexible organic electronics

Scientists at Osaka University in Japan are developing flexible sensor materials for detecting signals from the human body. The research involves soft, organic electronics and progress is being made with help from Leica microscopes. The ultimate goal is to create more biocompatible sensors which are comfortable to wear and make monitoring a person’s health more... Read more

July 9, 2017 Uncategorized

GE ouvre un nouveau centre de formation GETLA, destiné à ses employés et aux acteurs du secteur de l’énergie et de la santé

Alger, Algérie ; 6 Février : General Electric a annoncé aujourd’hui l’ouverture de son centre de formation, GETLA (General Electric Technical and Leadership Academy), situé au sein de la Tour CMA CGM, dans le quartier d’affaires de Bab Ezzouar à Alger. S’étendant sur une surface de plus de 650 m², GETLA est le premier centre de formation... Read more

July 7, 2017 Uncategorized

GE Healthcare и группа компаний «Медикер» подписали меморандум о стратегическом сотрудничестве

АСТАНА, Казахстан, 07 июля 2017 г.  – В рамках международной выставки ЭКСПО-2017 в Астане GE Healthcare и группа компаний «Медикер» подписали меморандум о взаимопонимании и стратегическом партнерстве. Документ предполагает сотрудничество в области проектирования и разработки комплексных решений в https://www.genewsroom.com/press-releases/ge-healthcare-%D0%B8-%D0%B3%D1%80%D1%83%D0%BF%D0%BF%D0%B0-%D0%BA%D0%BE%D0%BC%D0%BF%D0%B0%D0%BD%D0%B8%D0%B9-%C2%AB%D0%BC%D0%B5%D0%B4%D0%B8%D0%BA%D0%B5%D1%80%C2%BB-%D0%BF%D0%BE%D0%B4%D0%BF%D0%B8%D1%81%D0%B0%D0%BB%D0%B8-%D0%BC%D0%B5%D0%BC%D0%BE%D1%80%D0%B0%D0%BD%D0%B4%D1%83%D0%BC-%D0%BE-%D1%81%D1%82%D1%80%D0%B0%D1%82%D0%B5%D0%B3%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%BE%D0%BC Read more

July 6, 2017 Uncategorized

MTS Reprices $457 Million Senior Secured Term Loan B Facility

EDEN PRAIRIE, MN, July 6, 2017 /PRNewswire/ — MTS Systems Corporation (Nasdaq: MTSC), a leading global supplier of high-performance test systems and sensors, today announced that it successfully completed the repricing of its existing $457 million senior secured Term Loan B facility.  The new applicable rate is LIBOR plus 325 basis points, subject to a .75... Read more